Indication

Erythema nodosum leprosum

Erythema nodosum leprosum, also designated as a type 2 lepra reaction, is an acute or recurrent immune-mediated inflammatory complication occurring in patients with multibacillary forms of Hansen disease, primarily lepromatous and borderline lepromatous leprosy. Read more about Erythema nodosum leprosum

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Erythema nodosum leprosum therapies.

Showing 1–3 of 3 drugs

LAMPRENE (clofazimine)

LEPROSTATICS (SYSTEMIC SINGLE INGREDIENT)·ERYTHEMA NODOSUM LEPROSUM·+1
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Erythema nodosum leprosum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Erythema nodosum leprosum.

Erythema nodosum leprosum, also designated as a type 2 lepra reaction, is an acute or recurrent immune-mediated inflammatory complication occurring in patients with multibacillary forms of Hansen disease, primarily lepromatous and borderline lepromatous leprosy.

It affects the integumentary and nervous systems as well as multiple visceral organs, driven immunologically by circulating immune complex deposition, intense neutrophil infiltration, and systemic release of pro-inflammatory cytokines such as tumor necrosis factor-alpha.

Clinically, it presents with painful, tender crops of erythematous subcutaneous nodules or plaques frequently accompanied by high fever, malaise, peripheral neuritis, arthralgias, lymphadenopathy, and potentially organ-threatening complications such as iridocyclitis or orchitis.

Personalize your experience

Follow Erythema nodosum leprosum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it